Ditchcarbon
  • Customers
  1. Organizations
  2. Neuland Laboratories
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 2 days ago

Neuland Laboratories

Company website

Neuland Laboratories Limited, commonly referred to as Neuland Labs, is a prominent player in the pharmaceutical industry, headquartered in Hyderabad, India. Founded in 1984, the company has established itself as a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on quality and innovation, Neuland Labs offers a diverse range of products, including custom synthesis and contract manufacturing services. The company is renowned for its expertise in complex molecules and has achieved significant milestones, such as obtaining multiple regulatory approvals from global health authorities. Neuland Labs is well-positioned in the market, recognised for its commitment to sustainability and customer-centric solutions. Its strategic operational regions extend across North America, Europe, and Asia, making it a trusted partner for pharmaceutical companies worldwide.

DitchCarbon Score

How does Neuland Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

61

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Neuland Laboratories's score of 61 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

78%

Let us know if this data was useful to you

Neuland Laboratories's reported carbon emissions

In 2024, Neuland Laboratories reported total greenhouse gas emissions of approximately 56,000,000 kg CO2e, comprising 22,961,440 kg CO2e from Scope 1, 31,406,360 kg CO2e from Scope 2, and 3,036,820 kg CO2e from Scope 3 emissions. This reflects a significant reduction from 2023, where total emissions were about 60,000,000 kg CO2e, with Scope 1 at 27,442,350 kg CO2e, Scope 2 at 27,245,080 kg CO2e, and Scope 3 at 5,406,000 kg CO2e. Neuland Laboratories has committed to ambitious climate targets, having signed the Science Based Targets initiative (SBTi) to achieve net-zero emissions across all scopes by 2050. The company aims to reduce its absolute Scope 1 and 2 emissions by 58.8% by FY2034 from a FY2024 baseline, and Scope 3 emissions by 63.8% per ton of product manufactured within the same timeframe. Additionally, Neuland is targeting a 30% reduction in Scope 1 emissions from 2020 levels by 2030 and a 25% reduction in Scope 2 emissions by the same year. The company has also implemented measures to reduce coal consumption at its manufacturing facilities, which directly lowers Scope 1 emissions. Neuland's commitment to sustainability is further underscored by its focus on energy efficiency and optimising equipment usage to reduce indirect emissions from purchased energy consumption. Overall, Neuland Laboratories is actively working towards significant emissions reductions and has set clear targets to align with global climate goals, demonstrating its commitment to tackling climate change.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
21,134,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
19,598,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
0,000,000
0,000,000
0,000,000
0,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Neuland Laboratories's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Neuland Laboratories is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Neuland Laboratories is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lupin

IN
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Morepen

IN
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Iol Chemcials And Pharmaceuticals

IN
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Cipla

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Laurus Labs

IN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy